Navigation Links
Newly-Published Review of Promising Mesothelioma Drug Finds Value Questions Remain, According to Surviving Mesothelioma
Date:11/16/2015

A new report suggests that there are still questions on the value of the immunotherapy drug tremelimumab for mesothelioma, despite encouraging clinical trial results. Surviving Mesothelioma has just posted an article on the new report. Click here to read it now.

Doctors at the University of Salford in the UK combed the medical literature for information on the monoclonal antibody tremelimumab and decided that it is still too early to tell how much the drug may help people with malignant pleural mesothelioma.

According to study author Alice Guazzelli, a PhD researcher at the University of Salford, “Even though clinical efficacy has been preliminarily demonstrated, the cost/benefit ratio of this drug for this neoplasm is yet to be ascertained.”

The paper, published in the new issue of Opinion on Biological Therapy, says the results of the early mesothelioma trials of tremelimumab are “now under critical consideration”.

“Until a cure for mesothelioma can be found, every new potential treatment has to be subjected to this kind of cost/benefit analysis,” observes Alex Strauss, Managing Editor of Surviving Mesothelioma. “Combatting mesothelioma while preserving quality of life is always a balancing act.”

To learn more about tremelimumab and the findings of the new report, see Fighting Mesothelioma with Immunotherapy Drug Tremelimumab, now available on the Surviving Mesothelioma website.

Guazzelli, A, et al, “Tremelimumab for the treatment of malignant mesothelioma”, November 11, 2015, Expert Opinion on Biological Therapy, Epub ahead of print, http://www.ncbi.nlm.nih.gov/pubmed/26560442

For nearly ten years, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.

Read the full story at http://www.prweb.com/releases/2015/11/prweb13082279.htm.


'/>"/>
Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved


Related medicine news :

1. The Westchester Bank Receives A+ Rating In Performance Review of Over 6,900 Federally Insured U.S. Banks
2. Latest CURE Connections® Video Series Reviews the Risks of Chemotherapy-induced Nausea and Vomiting (CINV) and How to Prevent It
3. Quorum Review to Attend PRIM&R's 2015 Advancing Ethical Research Conference
4. Our Lady of Lourdes Medical Center Named to Becker’s Hospital Review List of 100 Hospitals with Great Heart Programs
5. Retro Review: Prototype Video Released By Cooper Idea Foundation for World Patent Marketing Clients
6. Finnleo Previewing New Sauna Products at IPSP Expo in Las Vegas
7. Police Foundation to Lead Review of Comprehensive Testing of Sexual Assault Kits in Texas
8. Becker’s Hospital Review to host the 7th Annual Meeting
9. Becker's Hospital Review Names 100 Hospitals & Health Systems with Great Heart Programs
10. BunionETTE Bootie Reviews Are In -BunionETTE Bootie is Gaining Rapid Acceptance Among Its Users
11. Vasont Systems Introduces an Enhanced Collaborative Review Tool for the Vasont Content Management System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2019)... SARASOTA, Fla. (PRWEB) , ... September 17, 2019 ... ... plans and Dental Service Organizations (DSOs) has earned Michael Cole, Vice President of ... presented today by the National Association of Dental Plans (NADP) at their annual ...
(Date:9/17/2019)... , ... September 17, 2019 , ... ... join the largest accountable care organization (ACO) in the country, the company announced ... groundbreaking collaboration to improve care quality and increase cost efficiency. This opportunity is ...
(Date:9/17/2019)... ... September 17, 2019 , ... Genomenon ... , with the goal of providing resources to assist researchers and encourage pharmaceutical ... progressive disease causing abnormal iron deposits in the brain. , BPAN Warriors ...
(Date:9/14/2019)... Okla. (PRWEB) , ... September 14, 2019 , ... ... cannabis industry, has time and again tried to bring the most relevant and important ... ray of hope on an increasingly large number of people across the world suffering ...
(Date:9/11/2019)... ... September 11, 2019 , ... Global Education Group (Global), ... (CME) provider, is the official accreditor for PAINWeek, the largest US pain conference ... topics, as it has done for the past ten years. In addition, the ...
Breaking Medicine News(10 mins):
(Date:9/12/2019)... ... September 12, 2019 , ... ... , revenue cycle management services, integrated practice management, and patient engagement solutions, ... Sponsor at National User Conference (NUCON) 2019 . The annual conference ...
(Date:9/11/2019)... ... September 12, 2019 , ... ... Best Practices, An FDAnews Webinar, Thursday, Sept. 26, 2019, 1:30-3:00 p.m. EDT, ... (DSCSA) implementation requirements? Is the company clear on nuances of the guidelines regulating ...
(Date:9/11/2019)... ... September 11, 2019 , ... Radiology… gastroenterology… ophthalmology… pathology… , ... evaluate medical images. In fact, image analysis software represents one of the fastest-growing ... to AI-based image analysis, one will be left behind. , As both a ...
Breaking Medicine Technology: